|
LYRM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.68359787117356E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.09270387077731E-11 |
| Normal-vs-Stage2 |
1.016410E-03 |
| Normal-vs-Stage3 |
3.362800E-03 |
| Normal-vs-Stage4 |
1.685580E-02 |
| Stage1-vs-Stage2 |
4.644800E-01 |
| Stage1-vs-Stage3 |
2.261200E-01 |
| Stage1-vs-Stage4 |
5.665200E-01 |
| Stage2-vs-Stage3 |
7.799800E-01 |
| Stage2-vs-Stage4 |
9.787000E-01 |
| Stage3-vs-Stage4 |
8.449000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64169788874347E-11 |
| Normal-vs-AfricanAmerican |
2.6482999999633E-06 |
| Normal-vs-Asian |
1.974020E-04 |
| Caucasian-vs-AfricanAmerican |
2.262800E-01 |
| Caucasian-vs-Asian |
8.055000E-01 |
| AfricanAmerican-vs-Asian |
5.235200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.6941565058396E-13 |
| Normal-vs-Female |
3.005400E-04 |
| Male-vs-Female |
1.758720E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.86699999999674E-05 |
| Normal-vs-Extreme_Weight |
2.105871033109E-12 |
| Normal-vs-Obese |
2.12849999958742E-07 |
| Normal-vs-Extreme_Obese |
1.191810E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.083190E-01 |
| Normal_Weight-vs-Obese |
9.225400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.268000E-01 |
| Extreme_Weight-vs-Obese |
2.067600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.189800E-01 |
| Obese-vs-Extreme_Obese |
8.498600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.959000E-04 |
| Normal-vs-Age(41-60Yrs) |
3.22580000045036E-07 |
| Normal-vs-Age(61-80Yrs) |
2.23487894857044E-12 |
| Normal-vs-Age(81-100Yrs) |
3.89290000000209E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.152000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.089800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.241930E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.684820E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.319900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.039200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64880331610107E-11 |
| Normal-VS-Type2 PRCC |
2.65750000005838E-07 |
| Normal-VS-KIRP CIMP |
1.389730E-02 |
| Normal-VS-Unclassified PRCC |
1.64754999999461E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.305000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.373970E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.226000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.398800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.350400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.398200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.51780041260474E-10 |
| Normal-vs-N1 |
1.183380E-01 |
| Normal-vs-N2 |
1.780480E-04 |
| N0-vs-N1 |
1.960460E-03 |
| N0-vs-N2 |
5.255600E-01 |
| N1-vs-N2 |
8.419900E-02 |
|
|
